![](https://www.isgltd.com/uk/-/media/images/isg/landing-pages/project/herobanner/healthcare-royal-free-0003.jpg?h=400&w=1560&hash=33E87E1AD98753E03301305B422A065A&usecustomfunctions=1¢ercrop=1 )
-
- Customer
- The Royal Free Hampstead NHS Trust
-
- Procurement Route
- Single stage
-
- Completion Date
- 01/03/2013
-
- Quantity Surveyor
- Huntley Cartwright
-
- Value
- £3m
-
- Form Of Contract
- JCT 11 SBC
-
- Project Manager
- Edmond Shipway
-
- Area
- 30,000 sq ft
-
- Program Duration
- 28 weeks
-
- Architect
- Ansell & Bailey
-
- ME Engineer
- WSP Group
![Royal_free_Band_image](https://www.isgltd.com/uk/-/media/images/isg/components/mediasection/image/royal_free_band_image.jpg?h=328&w=512&hash=B02F2BD2B40F629560E2FE81303988A0&usecustomfunctions=1¢ercrop=1 )
Overview
ISG was awarded the £3m refurbishment project as part of a programme to create a new Institute of Immunity, Infection and Transplantation at the Royal Free London NHS Foundation Trust.
The institute, a partnership development between the Royal Free and University College London (UCL), provides state-of-the-art facilities in which important immunity, infection and transplantation research can take place and new treatments be developed.
The Project
The 33-week project involved the refurbishment of existing accommodation on the second floor of the hospital. The 1,590 sq ft area was stripped to shell and core and remodelled to create a series of new laboratories, clinical trial patient units and offices. The fit out also included new Mechanical & Electrical services, including medical gases, a new nurse call system and installation of general medical and lab equipment.
The scheme was carried out in a live hospital environment in an area adjacent to occupied wards, with day clinics and a sleep centre directly below, and operating theatres occupying the floor above. A robust and flexible project programme was designed to incorporate out-of-hours working, with careful consideration given to accessing the building to minimise potential disruption to staff and patients.